Endovascular treatment of intracranial infectious aneurysms

Basit Öğe Kaydı
dc.authoridESENKAYA, ASIM/0000-0003-3692-2640
dc.authorwosidOran, Ismail/ABG-8329-2020
dc.contributor.authorEsenkaya, Asim
dc.contributor.authorDuzgun, Fatih
dc.contributor.authorCinar, Celal
dc.contributor.authorBozkaya, Halil
dc.contributor.authorEraslan, Cenk
dc.contributor.authorOzgiray, Erkin
dc.contributor.authorOran, Ismail
dc.date.accessioned2024-06-12T11:03:58Z
dc.date.available2024-06-12T11:03:58Z
dc.date.issued2016
dc.departmentTrakya Üniversitesien_US
dc.description.abstractIntracranial infectious aneurysm (IIA) accounts for less than 5 % of all intracranial aneurysms. The aim of this study was to evaluate the role of endovascular treatment for IIA. During a 14-year period, 15 patients (age range, 2-68 years; mean, 42.8 years) with 17 aneurysms were diagnosed with IIA and treated via an endovascular route at our institution. The IIA diagnosis was based on clinical and laboratory findings of infection, echocardiography results, and digital subtraction angiography that were collected retrospectively. All patients were clinically and radiologically followed. The modified Rankin scale was used to evaluate clinical outcome. Among 15 patients, 12 presented with ruptured aneurysms (7 intraparenchymal hematoma, 4 subarachnoid hemorrhage, 1 subdural hematoma), 2 with cerebral infarcts, and 1 with pansinusitis and epidural abscess. All but one aneurysm were distally located in intracranial circulation, 14 were in anterior, and the remaining 3 were in posterior circulation. The final diagnosis was based on aneurysm morphology, location, and clinical laboratory findings. Endovascular treatment was scheduled initially for all IIAs; 13 of 17 IIAs underwent endovascular parent vessel occlusion, 3 underwent spontaneous parent vessel occlusion while waiting for intervention, and the remaining patient was treated by intrasaccular coil occlusion. There were no instances of perioperative neurological complications. Late clinical and radiological outcomes included absence of endovascular treatment related to mortality and aneurysm recurrence. Endovascular treatment may be performed safely at the time of diagnosis for at least symptomatic IIAs under the protective effect of antibiotic treatment.en_US
dc.identifier.doi10.1007/s00234-015-1633-2
dc.identifier.endpage284en_US
dc.identifier.issn0028-3940
dc.identifier.issn1432-1920
dc.identifier.issue3en_US
dc.identifier.pmid26700825en_US
dc.identifier.scopus2-s2.0-84961171318en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage277en_US
dc.identifier.urihttps://doi.org/10.1007/s00234-015-1633-2
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21862
dc.identifier.volume58en_US
dc.identifier.wosWOS:000372307100007en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofNeuroradiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectIntracranial Infectious Aneurysmen_US
dc.subjectIntracranial Mycotic Aneurysmen_US
dc.subjectEndovascular Treatmenten_US
dc.subjectSubarachnoid Hemorrhageen_US
dc.subjectMycotic-Aneurysmsen_US
dc.subjectManagementen_US
dc.subjectInfarctionen_US
dc.subjectArteryen_US
dc.titleEndovascular treatment of intracranial infectious aneurysmsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu